Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

721
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
721
Depression: Overview01:18

Depression: Overview

777
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
777
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

ClassPass Memberships to Improve Well-Being Among Psychiatry Residents: A Pilot Randomized Controlled Trial.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2026
Same author

Educational Outcomes of a Longitudinal Women's Reproductive Mental Health Elective in Psychiatry Residency Training.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2026
Same author

Implicit Bias and Recognition of Biases Among Vascular Surgeons.

The Journal of surgical research·2026
Same author

Health Ratings and Unmet Transportation Needs in Indiana's Aged and Disabled Home and Community-Based Services Waiver Program.

Journal of aging & social policy·2025
Same author

Implicit Racial Bias and Unintentional Harm in Vascular Care.

JAMA surgery·2025
Same author

"Don't Give Up, Advocate for Yourself": A Pilot Study Examining Healthcare Experiences of People with Mayer Rokitansky Küster Hauser Syndrome.

Journal of pediatric and adolescent gynecology·2024

関連する実験動画

Updated: Jan 15, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.5K

周産期うつ病の現在の治療選択肢

Ashley Clark1, Lauren D'Andrea, Alison Reminick

  • 1Department of Psychiatry, University of California San Diego, La Jolla, California, USA.

Current opinion in obstetrics & gynecology
|January 14, 2026
PubMed
まとめ

周産期うつ病(PND)のスクリーニングと治療は、母親の健康にとって非常に重要です。新しい治療法とデジタルツールは、親と乳児の転帰を改善しますが、慎重な統合が必要です。

科学分野:

  • 産科および婦人科
  • 精神医学
  • 母体胎児医学

背景:

  • 周産期うつ病(PND)はかなりの患者に影響を与え、母体死亡率に寄与しています。
  • その有病率にもかかわらず、PNDは依然として診断および治療が不十分であり、母体医療における重大なギャップを浮き彫りにしています。
  • このレビューは、PNDのスクリーニング、治療、および新規治療アプローチに関する現在の知識を統合します。

研究 の 目的:

  • 周産期うつ病の更新された臨床的に関連性の高いレビューを提供すること。
  • PNDのスクリーニング方法、確立された治療法、および新たな治療法に関する現在のエビデンスを統合すること。
  • PNDの診断と管理に関する臨床実践に情報を提供すること。

主な方法:

  • 現在の文献および臨床ガイドラインの体系的なレビュー。
  • PNDの薬理学的および非薬理学的治療に関する最近の発見の分析。
  • PND管理のための新たな技術および介入精神医学の評価。

主要な成果:

  • 検証済みのツールを使用したPNDの普遍的なスクリーニングが推奨されます。
  • 選択的セロトニン再取り込み阻害薬は第一選択薬であり、妊娠中および授乳中の安全性を示しています。
キーワード:
神経ステロイド周産期うつ病産後うつ病選択的セロトニン再取り込み阻害薬ザヌラロン

さらに関連する動画

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

27.5K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

関連する実験動画

Last Updated: Jan 15, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.5K
Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

27.5K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K
  • 新たな治療法には、急速な産後うつ病の緩和のための神経ステロイドであるザヌラロンや、一部の患者に対するケタミンやTMSなどの介入精神医学的選択肢が含まれます。
  • デジタルツールとAIは、さらなる検証を保留して、早期発見と個別化された介入の可能性を示しています。
  • 結論:

    • PNDにおける母親と新生児の転帰を最適化するには、個別化されたエビデンスに基づいた治療が不可欠です。
    • 薬理学的および非薬理学的介入の組み合わせは、親と子の両方の転帰を大幅に改善できます。
    • 新しい治療薬とデジタルイノベーションはPNDケアに有望ですが、慎重な臨床統合が必要です。